|
|
|
|
| ORIGINAL ARTICLES |
  |
|
CMH
2000 December;6:488-494.
Published online 2000 January 01.
|
| Copyright © 2000 The Korean Association for the Study of the Liver |
|
|
| Efficacy of Lamivudine in Patients with HBeAg-Negative and HBV DNA-Positive Chronic Liver Disease |
| Hye Seung Yoo,Han Joo Lee,Young Hwa Jung,Young Sang Lee,Dong Jin Seo |
| Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea |
 |
| ABSTRACT |
|
|
| Background/Aims: The aim of this study was to evaluate the efficacy of lamivudine in patients with HBeAg-negative and HBV DNA-positive chronic liver disease. Methods: Twenty-four chronic liver disease patients were enrolled whose serology had common characteristics of HBeAg (-), and anti-HBe (+) but HBV DNA (+). All had elevated alanine aminotransferase (ALT) levels. 150mg of lamivudine was given orally once daily for more than 6 months. The goal of this treatment was the elimination of HBV DNA in serum and normalization of ALT level. Once HBV DNA disappearance and ALT normalization were observed, lamivudine was continued for two additional months. HBeAg, anti-HBe, HBV DNA and ALT were followed up every 1-2 month during, and after, treatment. Results: Median duration of treatment was seven months. HBV DNA became undetectable after a median one month of treatment and ALT activity was normalized in all 24 patients within six months. Among the sixteen patients who were followed for more than 12 months after cessation of treatment, six relapsed. The cumulative relapse rate at 12 months was 37.5%. Conclusion: Lamivudine suppresses HBV replication effectively and normalizes serum ALT in patients with HBeAg-negative and HBV DNA-positive chronic liver disease. The relapse rate after cessation of treatment seems to be relatively low. |
| Keywords: HBeAg negative, Hepatitis B virus , Chronic liver disease, Lamivudine |
|
 |
| Don't forget to sign up for journal e-mail alerts so you can keep up to date with all the articles as they are published. |
|
 |
 |
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 Register for e-submission |
|
Register here to access the e-submission system of CMH for authors and reviewers.
|
| Manuscript Submission |
|
To submit a manuscript, please visit the CMH e-submission management system at http://submit.e-cmh.org, read the Instructions for Authors, and log into the CMH e-submission system. For assistance with manuscript submission, please contact: kasl@kams.or.kr.
|
| Free archive |
|
Anyone may access any past or current articles without logging in.
|
|
|
|
The Korean Association for the Study of the Liver
|
Room A1210, 53 Mapo-daero{MapoTrapalace , Dowha-dong}, Mapo-gu, Seoul, 121-784, Korea
TEL : +82-2-703-0051 FAX : +82-2-703-0071 E-mail : kasl@kams.or.kr |
Copyright © By The Korean Association for the Study of the Liver. All right reserved. 
|
|
|
| |